Empiric amphotericin B therapy: the need for a reappraisal
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 7 (4) , 208-214
- https://doi.org/10.1016/0268-960x(93)90007-q
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendationsJournal of Antimicrobial Chemotherapy, 1993
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?Chemotherapy, 1992
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989
- Predictive value of surveillance cultures for systemic infection due toCandida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Empiric Amphotericin B Therapy in Patients with Acute LeukemiaClinical Infectious Diseases, 1985
- Clinical value of empirical amphotericin B in patients with acute myelogenous leukemiaCancer, 1982
- Fungal infections in patients with acute leukemiaThe American Journal of Medicine, 1982
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982
- The Value of Fungal Surveillance Cultures as Predictors of Systemic Fungal InfectionsThe Journal of Infectious Diseases, 1980